Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by enriquesuaveon Aug 30, 2023 7:15pm
130 Views
Post# 35612914

RE:RE:my thoughts and questions

RE:RE:my thoughts and questions
2b7f6fab wrote:
Condensing the corn cob down to a kernel.  The loss for six months was approx $2.6 million less .5 million for non cash expenses give a six month burn of $2.1 million.  So about $350,000 per month. 

Quote from the press release- The net loss for the six-month period ended June 30th, 2023, was $2,564,187, which included $474,558 of net non-cash expenses (i.e.: amortization, stock-based compensation expense and foreign exchange gain/loss).

Also note the net loss for the three months ended June 30 was $1,155,234.  Considerably less than the loss for the three months ended March 31 of approx $1.4 million. 

There are 10,280,000 stock options fully vested with a price of 26 cents with a remaining life of about a year.  And 4.1 million stock warrants with a price of 50 cents good till early January.  A nice pop in the stock price and cash will be flowing.  So cheer up!

There is also about 15 Million warrants from recent PP's at 0.35 cents.  About $5 Million.

<< Previous
Bullboard Posts
Next >>